×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Overview
This workshop will be conducted in Japanese Language only.
Click Here to View the Program in Japanese
Online Registration has been closed. Onsite Registration will be available at Nihonbashi Life Science HUB.
Program Committee
-
Shinzo Hiroi, PhD, MPH, RPh, PMP Head of Global Medical Affairs
Shionogi & Co., Ltd., Japan -
Kentaro Kogushi, PhD Head of Clinical Development Neurology-Psychiatry, Japan Development
AbbVie GK, Japan -
Yusuke Nakamura, MBA, MPH Pharmaceuticals Division, Market Acccess
Bayer Yakuhin, Ltd., Japan -
Shinya Ohno, PhD, MPH Director, HTA Strategy Professional
Chugai Pharmaceutical Co., Ltd, Japan -
Masayo Sato
Eli Lilly Japan K.K., Japan -
Akihito Uda, MPH HEOR Group, Market Access and Public Affairs Division
Novartis Pharma K.K., Japan -
Hisashi Urushihara, DrPH Professor, Faculty of Pharmacy, Department of Pharmacy
Keio University, Japan -
Manami Yoshida, DVM Associate Director, Medical Affairs – HIV & COVID-19
Gilead Sciences K.K., Japan -
Hiroyuki Sakamaki, DrSc, PhD, MBA Professor, School of Health Innovation
Kanagawa University of Human Services, Japan -
Kuniko Shoji Vice-Dean, School of Health Innovation
Kanagawa University of Human Services, Japan
Have an account?